Others
Latest
- In the Picture: Medical Imaging Datasets, Artifacts, and their Living Review
- Measuring and interpreting individual differences in fetal, infant, and toddler neurodevelopment
- Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
- NeuroImaging of Babies during natural Sleep to assess typical development and Cerebral Palsy (NIBS-CP)
- PET2BIDS: a library for converting Positron Emission Tomography data to BIDS
- Publisher Correction: Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
- The past, present, and future of the brain imaging data structure (BIDS)
- AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale
- Cerebral Palsy--Early Diagnosis and Intervention Trial: protocol for the prospective multicentre CP-EDIT study with focus on diagnosis, prognostic factors, and intervention
- Deep phenotyping towards precision psychiatry of first-episode depression—the Brain Drugs-Depression cohort
- Postprocessing of MRIs using FreeSurfer in epilepsy surgery patients provides an excellent imaging marker of hippocampal sclerosis but fails to separate subtypes
- Research Article Postprocessing of MRIs Using FreeSurfer in Epilepsy Surgery Patients Provides an Excellent Imaging Marker of Hippocampal Sclerosis but Fails to Separate Subtypes
- The art, science, and secrets of scanning young children
- Why is the winner the best?
- Biomedical image analysis competitions: The state of current participation practice
- Emotional faces processing in major depressive disorder and prediction of antidepressant treatment response: a NeuroPharm study
- Evaluating the performance of markerless prospective motion correction and selective reacquisition in a general clinical protocol for brain MRI
- Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
- Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
- Open and reproducible neuroimaging: from study inception to publication
- PET-BIDS, an extension to the brain imaging data structure for positron emission tomography
- Centering inclusivity in the design of online conferences—An OHBM--Open Science perspective
- NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD
- P. 0054 The braindrugs-epilepsy cohort-precision medicine in the treatment of epilepsy
- Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: independent validation from the NeuroPharm study
- The positron emission tomography brain imaging data structure (PET-BIDS) extension: A new standard for sharing PET data
- Guidelines for the content and format of PET brain data in publications and archives: a consensus paper
- Predicting treatment outcome in major depressive disorder using serotonin 4 receptor PET brain imaging, functional MRI, cognitive-, EEG-based, and peripheral biomarkers: a neuropharm open label clinical trial protocol
- Cerebral serotonin transporter measurements with [11C] DASB: a review on acquisition and preprocessing across 21 PET centres
- Comparing fully automated state-of-the-art cerebellum parcellation from magnetic resonance images
- Serotonin 2A receptor agonist binding in the human brain with [11C] Cimbi-36: test--retest reproducibility and head-to-head comparison with the antagonist [18F] altanserin
- Relevant feature set estimation with a knock-out strategy and random forests
- Serotonin 2A receptor agonist binding in the human brain with [11C] Cimbi-36: test-retest reproducibility and comparison with [18F] altanserin